← Portfolio Scout

Portfolio company

ArkVax

United Kingdom

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechFood & Agritech

About

ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies